X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Recipharm supports FDA approval of Perrigos AB-rated generic product

    FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

    authorisation for roxadustat in China

    ABPI and NHS Are in Talks for New Medicines Scheme in the UK

    New Approach To Gene Editing For Improved Cancer Treatment

    Report Predicts OSD Contract Manufacturing Market Growth

    Driving Factors Behind Digital Bioprocessing Market Growth

    FDA Draft Guidance Supports Decentralized Clinical Trials

    Pharma Industry Groups Criticise Proposed EU Drug Regulation

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Recipharm supports FDA approval of Perrigos AB-rated generic product

    FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

    authorisation for roxadustat in China

    ABPI and NHS Are in Talks for New Medicines Scheme in the UK

    New Approach To Gene Editing For Improved Cancer Treatment

    Report Predicts OSD Contract Manufacturing Market Growth

    Driving Factors Behind Digital Bioprocessing Market Growth

    FDA Draft Guidance Supports Decentralized Clinical Trials

    Pharma Industry Groups Criticise Proposed EU Drug Regulation

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

ABPI and NHS Are in Talks for New Medicines Scheme in the UK

Content Team by Content Team
8th May 2023
in FDA Approvals, News
authorisation for roxadustat in China

The government of the UK, NHS England, as well as the Association of the British Pharmaceutical Industry have gone on to open new negotiations for a novel voluntary scheme when it comes to branded medicine pricing and access.

As per a May 4 press release by the government, these negotiations look to create a novel scheme that can help in furthering the development of cost-effective as well as innovative medicines and also support the economic growth of the UK, besides contributing financially to a sustainable NHS. These negotiations went on to begin after the government held a debate pertaining to the matter on May 3.

The January 2019 scheme went on to keep the expenditure of the NHS on medicines that are branded within a limit that was agreed, which elevated by 2% per year between 2018 and 2023. So as to keep this within the limits, the pharma companies have gone on to pay rebates when it comes to sales back to the NHS across all the expenditures over and above the capped limit. Companies that opted not to take part in the voluntary scheme have to take part in a statutory scheme.

Both schemes are designed to complement each other and make up the total medicine costs by wanting pharma companies to make clawback payments.

As per a statement released by ABPI, there were concerns raised that the present voluntary scheme may not gel with the purpose in a post-pandemic scenario. Because of the high demand from the NHS, payments went on to rise quite significantly, much above historic levels, thereby having a major effect on the life sciences sector in the UK. In recent years, medical sales have rapidly grown, and the scheme has also adjusted to the growth witnessed. As per the strategy report, which is prepared by the public affairs consultancy, this has gone on to elevate the rate of payment from 5.1% in 2021 to 15% in 2022 and recently to 26.5% this year.

Will Quince, the health minister of the UK, opined the negotiations will assure that the new scheme continues to give out value for money by way of providing significant savings when it comes to health services, getting access to novel and lifesaving medicines for NHS patients, and also aiding in the reduction of waiting times, which is one of the Prime Minister’s 5 priorities.

The revised voluntary scheme will float on January 1, 2024, and will replace the current scheme, which ends on December 31st this year. The chief executive of ABPI opined that working in tandem, they can all push UK sciences and also create conditions so as to deliver their rightful value when it comes to the country’s health, productivity, and prosperity.

Previous Post

New Approach To Gene Editing For Improved Cancer Treatment

Next Post

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

Related Posts

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity
Drug Development

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

8th May 2023
Recipharm supports FDA approval of Perrigos AB-rated generic product
Drug Development

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

8th May 2023
News

New Approach To Gene Editing For Improved Cancer Treatment

6th May 2023
Drug Development

Report Predicts OSD Contract Manufacturing Market Growth

6th May 2023
Drug Development

Driving Factors Behind Digital Bioprocessing Market Growth

6th May 2023
IPR Data Management

Harnessing Blockchain Technology For Better Pharma Functions

6th May 2023
Next Post
Recipharm supports FDA approval of Perrigos AB-rated generic product

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

Latest News

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity
Drug Development

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

8th May 2023
Recipharm supports FDA approval of Perrigos AB-rated generic product
Drug Development

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

8th May 2023
authorisation for roxadustat in China
FDA Approvals

ABPI and NHS Are in Talks for New Medicines Scheme in the UK

8th May 2023
News

New Approach To Gene Editing For Improved Cancer Treatment

6th May 2023
Drug Development

Report Predicts OSD Contract Manufacturing Market Growth

6th May 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In